KLK7 and Hyperkeratosis: In addition, the ARNT-null epidermis exhibits the upregulation of secretory leukocyte protease inhibitor (Slpi), which inhibits stratum corneum chymotryptic enzyme (kallikrein 7), leading to hyperkeratosis due to impaired corneodesmosome degradation and delayed detachment of corneocytes [18].